Jonathan Gerber interviews Ziv Kalfon, CEO of Allevetix Medical
Allevetix Medical is a global leader in innovative medical technology focusing on the treatment of metabolic diseases, such as Type II Diabetes, Obesity, and Nonalcoholic Steatohepatitis. Allevetix’s NobiX System is a non-surgical, fully reversible, and natural treatment designed to mimic the effects of gastric bypass surgery without the need for cuts or ablations. It consists of a safe and non-invasive implant that prevents food contact with a section of the small intestine linked to the hormone abnormality in the case of metabolic disease.
In the interview, Ziv discusses Allevetix and the progress of their current clinical studies. He hopes the treatment will be available for the public in 3-5 years
For more information, please visit www.allevetix-medical.com